Processing

Please wait...

Settings

Settings

Goto Application

1. WO1992018152 - USE OF MÜLLERIAN INHIBITING SUBSTANCE FOR TREATMENT OF CERTAIN TUMORS

Publication Number WO/1992/018152
Publication Date 29.10.1992
International Application No. PCT/US1992/003041
International Filing Date 13.04.1992
Chapter 2 Demand Filed 04.11.1992
IPC
A61K 38/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
A61K 38/22 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
A61K 48/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
C07K 14/575 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
575Hormones
C07K 16/26 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
26against hormones
CPC
A61K 33/24
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
A61K 33/243
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
243Platinum; Compounds thereof
A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
A61K 38/22
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61K 48/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applicants
  • THE GENERAL HOSPITAL CORPORATION [US]/[US]
Inventors
  • DONAHOE, Patricia, K.
  • CHIN, Taiwai
  • PARRY, Robert, L.
  • EPSTEIN, James
  • RAGIN, Richard, C.
  • MacLAUGHLIN, David, T.
Agents
  • GOLDSTEIN, Jorge, A.
Priority Data
683,96612.04.1991US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) USE OF MÜLLERIAN INHIBITING SUBSTANCE FOR TREATMENT OF CERTAIN TUMORS
(FR) UTILISATION DE L'HORMONE ANTIMULLERIENNE POUR LE TRAITEMENT DE CERTAINES TUMEURS
Abstract
(EN) This application concerns the treatment of certain tumors using an effective amount of the glycoprotein Müllerian Inhibiting Substance. In particular, this application concerns the treatment of vulvar epidermoid carcinomas, cervical carcinomas, endometrial adenocarcinomas, ovarian adenocarcinomas, and ocular melanomas. Pharmaceutical compositions which can be used in such treatment are also disclosed.
(FR) Cette invention se rapporte au traitement de certaines tumeurs, lequel consiste à utiliser une quantité efficace de l'hormone glycoprotéique antimüllérienne. En particulier, l'invention concerne le traitement de carcinomes épidermoïdes vulvaires, de carcinomes cervicaux, d'adénocarcinomes endométriaux, d'adénocarcinomes ovariens et de mélanomes oculaires. On décrit aussi des compositions pharmaceutiques qui peuvent être utilisées dans le cadre de ce traitement.
Latest bibliographic data on file with the International Bureau